INVIVO CYTOGENETIC ACTIVITY OF SULFONYLUREA DRUGS IN MAN

被引：17

作者：

WATSON, WAF

PETRIE, JC

GALLOWAY, DB

BULLOCK, I

GILBERT, JC

机构：

[1] UNIV ABERDEEN, DEPT GENET, ABERDEEN, SCOTLAND

[2] UNIV ABERDEEN, DEPT THERAPEUTICS & CLIN PHARMACOL, ABERDEEN, SCOTLAND

[3] UNIV ABERDEEN, DEPT PHARMACOL, ABERDEEN, SCOTLAND

来源：

MUTATION RESEARCH | 1976年 / 38卷 / 01期

关键词：

D O I：

10.1016/0165-1161(76)90080-7

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

页码：71 / 80

页数：10

共 32 条

[1]

BARTHELMESS A, 1970, CHEMICAL MUTAGENESIS, P69

[2]

Buckton KE, 1967, HUMAN RAD CYTOGENETI, P122

[3] ONE YEAR OF CLINICAL EXPERIENCE WITH CHLORPROPAMIDE IN MORE THAN 100 DIABETIC PATIENTS [J].

BURRELL, ZL ;

MARTINEZ, A ;

BURRELL, LO .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1959, 74 (03) :696-700

[4]

CAMPBELL GD, 1969, PREFACE ORAL HYPOGLY

[5] BLOOD LEVELS OF CHLORPROPAMIDE IN NORMAL MEN FOLLOWING CHRONIC ADMINISTRATION [J].

CARLOZZI, M ;

IEZZONI, DG ;

SILVER, L .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1959, 74 (03) :788-793

[6]

COURTBROWN WM, 1967, HUMAN POPULATION CYT

[7]

COURTBROWN WM, 1967, HUMAN RADIATION CYTO, P114

[8]

COURTBROWN WM, 1966, 42 U COLL GALT LAB E

[9]

De Meyer R, 1958, Ann Endocrinol (Paris), V19, P167

[10]

EVANS HJ, 1961, GENETICS, V46, P257

← 1 2 3 4 →